Wednesday, September 28

11:30 AM

Seminar Registration Opens and Luncheon

12:00 PM–1:15 PM

PRE-SEMINAR SESSION
Prepare for Launch: Distribution 101
This optional pre-seminar session is designed to help pharmaceutical manufacturers put their channel strategies in context with the services and expertise of healthcare distributors to successfully commercialize new products. This presentation will include a focus on trends in the specialty sector of the industry, explaining the difference between specialty distribution and specialty pharmacy.

This session is ideal for manufacturers of non-traditional products or products in the development pipeline or those interested in learning more about healthcare distribution trends, distribution channel options and trade policies.

Speaker: Robert B. Glasgow, Senior Vice President, Commercial Solutions, ABC Specialty Distribution Services, AmerisourceBergen Corporation

1:30 PM–1:35 PM

Welcome and Seminar Overview
Perry Fri, Senior Vice President, Industry Relations, Membership & Education, HDMA

1:35 PM–2:15 PM

Launch Excellence
This high-level keynote presentation will provide the latest trends in new product introductions across multiple product classes. This presentation will describe the performance of recently launched products and provide an overview of today’s challenging and complex biopharmaceutical environment. In addition, the session will examine the drivers of uptake and foundational success factors every company must address when launching new products.

Speaker: Rob Harold, Senior Principal, IMS Health, Inc.

2:15 PM–2:45 PM

Product Introduction Case Studies
Learn how industry experts have successfully launched new items  across multiple product classes — not necessarily because they were blockbusters, but because of the high level of coordination taking place across the supply chain.

Gain insights from their experiences and discover best practices for taking new products to market — both generic and branded. This session will explore lessons learned, highlight potential new opportunities and identify critical challenges your company will want to overcome.

Speaker: Troy W. Jordan, Associate Director, Trade & Distribution, Vertex Pharmaceuticals, Inc.

2:45 PM–3:30 PM

THE GOOD LIFE
Product Introductions and Supply Chain Planning
Building a solid commercialization strategy is the key to a successful product launch. Hear from distributors and retailers who will describe the supply chain implications of commercializing a pharmaceutical product and the necessary roles and responsibilities for your company to make this happen.

This interactive session also will ask key questions and identify factors that contribute to successful launches, including benchmarking data, quarterly expectations, sales force training, detailing, packaging and handling information and much more.

Speakers: Thomas Doyle, Vice President, Business Development / Specialty Solutions, Smith Medical Partners (a wholly owned subsidiary of H. D. Smith)
David J. Fong, PharmD, President, Rx Consulting, Inc.
Will K. Stripling, Director of Business Development & Pharmacy Supply Chain, H-E-B

3:30 PM–4:00 PM

Networking Break and Table-Top Exhibits

4:00 PM–4:45 PM

Strengthening Trading Partner Relationships
Beyond learning about the important elements of building a solid commercialization strategy, effectively managing business relationships and supply chain partnerships is key to any company’s success to efficient supply chain management and, ultimately, to meeting the needs of the customer.

This session will focus on the importance of trading partner relationships throughout the life cycle management process. Although the traditional role of trade relations has evolved over the years, the ability to connect diverse silos and multiple business units and proactively build relationships remains critical.  Discussion will include launch support and provide a look into the supply chain activities that make up “the rest of the story.”

Speaker: John Fiacco, Vice President, Medicine Shoppe International
Neil Warren, Vice President, Industry & Supplier Relations, Cardinal Health, Inc.

4:45 PM–5:30 PM

Roundtable Discussions: Part One
Roundtable discussions provide an opportunity to learn in small groups through peer discussion of key issues, obstacles and potential solutions. Be ready to identify if there are “successes” or “goal states.” This will help drive greater awareness and action to share during the “Report Back — Lightning Round” discussion.

Topics and Facilitators:

1. NDC Changes
Michael G. Ladewski, Associate Director, Trade & Distribution, Amylin Pharmaceuticals, Inc.

2. Named Patient Programs
Teri Gautier, President & CEO, Pharmaceutical Trade Services, Inc.

3. Launch Issues
Robert B. Glasgow, Senior Vice President, Commercial Solutions, ABC Specialty Distribution Services, AmerisourceBergen Corporation

4. Data Availability and Management
David J. Fong, PharmD, President, Dave Fong Rx Consulting, Inc.

5. Hazardous Waste / Consumer Commodity Q&A
Keith Anderson, Senior Director, Regulatory Compliance, Inmar, Inc.

5:30 PM–6:00 PM

Report Back — Lightning Round
Debrief from the roundtable discussions and learn from your peers during this interactive discussion. Come ready to share your comments, questions and insights.

6:00 PM–7:00 PM

Networking Reception and Table-Top Exhibits

7:00 PM

Open Evening

Thursday, September 29

7:30 AM–8:30 AM

Continental Breakfast

8:30 AM–9:00 AM

Serialization: A Perfect World
The second day will kick off with a high-level, future-focused presentation on how the pharmaceutical supply chain will look and act in a serialized environment. Product life cycle management issues, as well as the regulatory and industry forces that are driving adoption in 2015 will be explored.

Speaker: Ron Bone, Senior Vice President, Distribution Operations, McKesson Corporation

9:00 AM–10:00 AM

MID-LIFE CRISIS
Panel Discussion: Challenges of Managing Exceptions
This supply chain panel will examine the challenges that arise in the middle of a product’s life cycle for a variety of reasons, including NDC changes or SKU transitions, mergers and acquisitions of any supply chain entity, formulary changes, generic launches, security issues or product shortages. This discussion will explore the ripple effects created by any of these issues, as well as the impact on returns and the product’s bottom line.

Panelists: Mike Bleser, Divisional Vice President, Rx Supply Chain & Analytics, Walgreen Co.
Walter Kaczmarek, Vice President, National Accounts - Fougera, PharmaDerm & Savage Laboratories, Fougera, a division of Nycomed US, Inc.

10:00 AM-10:30 AM

Networking Break and Table-Top Exhibits

10:30 AM-11:15 AM

Roundtable Discussions: Part Two
Take advantage of another opportunity to participate in roundtable discussions. Be ready to identify if there are “successes” or “goal states.” This will help drive more awareness and action to share during the “Recap and Looking Forward” discussion.

Topics and Facilitators:

1. Serialization
Ron Bone, Senior Vice President, Distribution Operations, McKesson Corporation

2. Managing Down a Brand and Other Mid-life Issues

3. Product Shortages
Perry Fri, Senior Vice President, Industry Relations, Membership & Education, HDMA

4. Data Availability and Management
Walter Kaczmarek, Vice President, National Accounts - Fougera, PharmaDerm & Savage Laboratories, Fougera, a division of Nycomed US, Inc.

5. Hot topic selected by the attendees

11:15 AM-12:00 PM

GOLDEN YEARS
End of Life Issues
Products that have expired, been discontinued or have to be recalled or withdrawn for a variety of reasons still impact a product’s bottom line, long after their actual return or disposition. Despite the efficiencies that have been built into the reverse logistics process to better account for and manage products that are not dispensed within their useful life, are there still gaps we can address as a supply chain to prevent returns?

This session will explore inventory management questions that arise throughout the supply chain surrounding the location of aging product and visibility into actual stock-keeping units (SKUs).

Potential topics to discuss include:

• Do we see a way for brands to have demand at the end of their lives?
  
• Can packaging decisions upstream actually minimize returns?
  
• How does loss of exclusivity impact product availability issues and affect reverse logistics?
  
• How are current market dynamics impacting returns policies and practices?
  
• Can we ultimately reduce the volume of products that become waste?
  

Speakers: Scott Bradford, Vice President, Reverse Logistics, McKesson Corporation
Joe Duda, Vice President of Sales Operations, Mylan Pharmaceuticals
Glenn Okoniewski, Senior Manager of Trade Logistics, Eisai, Inc.

12:00 PM-12:30 PM

Recap and Looking Forward
The seminar concludes with an open discussion on the insights gained from the program and potential forward-looking actions to continue to foster conversation on issues relating to product life cycle management.

• What ideas do you have after an immersion of product life cycle issues? 
• What issues can HDMA help address? 
• What supply chain topics are most important for the industry going forward? What education should come next?
• What advice do we have for the rising leaders in the industry who will need to find solutions to complex challenges ahead? 

12:30 PM

Seminar Adjournment